Litcius/Paper detail

CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results

Jae H. Park, Karthik Nath, Sean M. Devlin, Craig S. Sauter, M. Lia Palomba, Gunjan L. Shah, Parastoo B. Dahi, Richard J. Lin, Michael Scordo, Miguel‐Angel Perales, Roni Shouval, Ana Alarcón Tomás, Elizabeth Cathcart, Elena Mead, Bianca Santomasso, Andrei I. Holodny, Renier J. Brentjens, Isabelle Rivière, Michel Sadelain

2023Nature Medicine165 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAnakinraInternal medicineCytokine release syndromeOncologyChimeric antigen receptorImmunotherapyDiseaseCancerCAR-T cell therapy researchIntegrated Circuits and Semiconductor Failure AnalysisAdvancements in Semiconductor Devices and Circuit Design
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results | Litcius